HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning.

Abstract
A patient developed progressive right hemidystonia in childhood. Subsequently, left-sided blepharospasm, slurred and stuttering speech, and right-sided rigidity and bradykinesia, responsive to dopamine agonists, appeared. Investigation with computed tomography and magnetic resonance imaging (MRI) at age 43 years revealed a left-sided calcified rostral brainstem-thalamic lesion of uncertain aetiology. Although no structural lesion was seen in the striatal regions, L-[18F]-fluorodopa uptake was severely diminished in the left striatum but normal on the right. Dopamine receptor binding identified by [11C]-methylspiperone was in the normal range on both sides.
AuthorsK L Leenders, R S Frackowiak, N Quinn, D Brooks, D Sumner, C D Marsden
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 1 Issue 1 Pg. 51-8 ( 1986) ISSN: 0885-3185 [Print] United States
PMID2973558 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Receptors, Dopamine
  • Receptors, Dopamine D2
Topics
  • Adult
  • Blepharospasm (pathology)
  • Brain Stem (pathology)
  • Corpus Striatum (metabolism)
  • Dystonia (pathology)
  • Eyelid Diseases (pathology)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Parkinson Disease (pathology)
  • Receptors, Dopamine (metabolism)
  • Receptors, Dopamine D2
  • Thalamus (pathology)
  • Tomography, Emission-Computed
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: